April 5, 2021 at 10:32 am Published by NCV Newswire Subversive Acquisition LP Announces InterCure’s Letter of Intent Relating to the Acquisition of a Multi-National Medical Cannabis Producer, Better Holdings InterCure Signs Letter of Intent with Cann Pharmaceutical Ltd. Acquisition Strengthens InterCure’s Position as the Largest Cannabis Company Outside of North America TORONTO, April 05, 2021 (GLOBE NEWSWIRE) — SUBVERSIVE ACQUISITION LP (TSX: SVX.U, NEO: SVX.U, OTCQX: SBVRF) (“SVX”) announced today that InterCure Ltd. (dba Canndoc) (TASE: INCR) (“InterCure”), Israel’s leading cannabis company and SVX’s intended target for its “Qualifying Transaction” (the “Transaction”), has signed a Letter of Intent (“LOI”) with Cann Pharmaceutical Ltd. (“Cann”) to acquire Better Holdings (“Better”), a pioneering medical cannabis operator in Israel and Australia. Under the terms of the agreement, InterCure will acquire 100% of Cann’s shares, which includes Better’s operations in Israel and 50% of Cann Pharma’s shares, which owns the commercial rights to develop cannabis-based medical products.